日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Polyvalent human immunoglobulin for infectious diseases: Potential to circumvent antimicrobial resistance

用于传染病的多价人免疫球蛋白:有望克服抗菌素耐药性

Pedraza-Sánchez, Sigifredo; Cruz-González, Adrián; Palmeros-Rojas, Oscar; Gálvez-Romero, José Luis; Bellanti, Joseph A; Torres, Martha

Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study

环孢素A联合低剂量类固醇治疗COVID-19可改善中重度患者的临床结局:一项初步研究

Gálvez-Romero, J L; Palmeros-Rojas, O; Real-Ramírez, F A; Sánchez-Romero, S; Tome-Maxil, R; Ramírez-Sandoval, M P; Olivos-Rodríguez, R; Flores-Encarnación, S E; Cabrera-Estrada, A A; Ávila-Morales, J; Cortés-Sánchez, V; Sarmiento-Padilla, G; Tezmol-Ramírez, S E; Aparicio-Hernández, D; Urbina-Sánchez, M I; Gómez-Pluma, M Á; Cisneros-Méndez, S; Rodríguez-Rivas, D I; Reyes-Inurrigarro, S; Cortés-Díaz, G; Cruz-Delgado, C; Navarro-González, J; Deveaux-Homs, J; Pedraza-Sánchez, S

Reply letter to: Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: Are concentrations required clinically achievable?

回复信:使用钙调磷酸酶抑制剂抑制 SARS-CoV-2 复制:临床上所需的浓度是否可达到?

Gálvez-Romero, J L; Deveaux-Homs, J; Real-Ramírez, F A; Palmeros-Rojas, O; Pedraza-Sánchez, S